Z-2750-2017 Class II Terminated
FDA device recall Z-2750-2017 was initiated by Becton Dickinson & Company on Sep 16, 2016 and is designated Class II. Reason for recall: BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required. The recall status is terminated (terminated Mar 20, 2018). Affected quantity: 340,000 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 26, 2017
- Initiation Date
- Sep 16, 2016
- Termination Date
- Mar 20, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 340,000 units
Product description
BD 3ml Syringe Luer-Lok" Tip with BD PrecisionGlide" Needle 18G x 1 1/2 (1.2mm x 40mm) Catalog #309580 The BD Single Use, Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection
Reason for recall
BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required.
Distribution pattern
Nationwide Distribution
Code information
6090832 2021-03 6176715 2021-06
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2750-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026